May 7 (Reuters) - Privately held contract manufacture
Future Pak said on Tuesday it will include contingent value
rights as part of its buyout offer of Vanda Pharmaceuticals ( VNDA )
, in addition to its proposed cash offer price of $7.25
to $7.75 per share for the drugmaker.